BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10796463)

  • 1. Surfactant for meconium aspiration syndrome in full term infants.
    Soll RF; Dargaville P
    Cochrane Database Syst Rev; 2000; (2):CD002054. PubMed ID: 10796463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant for meconium aspiration syndrome in full term/near term infants.
    El Shahed AI; Dargaville P; Ohlsson A; Soll RF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002054. PubMed ID: 17636695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant for meconium aspiration syndrome in term and late preterm infants.
    El Shahed AI; Dargaville PA; Ohlsson A; Soll R
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD002054. PubMed ID: 25504256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung lavage for meconium aspiration syndrome in newborn infants.
    Hahn S; Choi HJ; Soll R; Dargaville PA
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003486. PubMed ID: 23633311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD000141. PubMed ID: 10796305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2000; (2):CD000510. PubMed ID: 10796379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD000144. PubMed ID: 10796308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant therapy for meconium aspiration syndrome: current status.
    Dargaville PA; Mills JF
    Drugs; 2005; 65(18):2569-91. PubMed ID: 16392874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis.
    Natarajan CK; Sankar MJ; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S49-54. PubMed ID: 27109092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue high frequency oscillatory ventilation vs conventional ventilation for infants with severe pulmonary dysfunction born at or near term.
    Bhuta T; Clark RH; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2001; (1):CD002974. PubMed ID: 11279790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.